A river model to map convergent cancer evolution and guide therapy in RCC.
about
Renal cell carcinoma.The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma.Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma.Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysisAn Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.Genomic characterisation of two cancers of unknown primary cases supports a kidney cancer origin.Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer.Precision medicine from the renal cancer genome.Targeted therapies for renal cell carcinoma.The difficulty in selecting patients for cytoreductive nephrectomy: An evaluation of previously described predictive models.A braided cancer river connects tumor heterogeneity and precision medicineTherapeutic Guide for mTOuRing through the Braided Kidney Cancer Genomic RiverComparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components.Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes.The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation.Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.
P2860
Q30235364-CD8E71FE-F68E-4C0C-9D5F-2620DD6AABAAQ33683959-D8799969-3985-41DD-8E4F-70273221E32FQ33798092-03B0A266-6160-4994-A714-EF404AD10318Q36367103-2EB65BCC-9020-46C9-AEBE-B763D6C0EBD2Q36732789-33B1DA47-1F45-4F24-8EDC-2A120F25F0A8Q37217474-C8F6AFB9-8A46-480F-BAEC-E8DFD7391150Q38614628-747CA655-8435-4D13-BAE3-323FF4E5F54FQ38822454-C5F1C923-D0F5-4C4A-8A1B-A17055EAB195Q38970282-5E420ADE-4571-40CD-9878-1F57051B72BBQ39425380-31B60E67-47E9-4704-870C-CFC82790FA66Q40604822-EF864D5E-EEF7-46D2-A890-E3C1F8ECEC43Q41522111-759F44B9-92F3-40BF-A8A1-F596C22D30E5Q41787565-16BB28F0-EBA2-4B79-B96A-323DB9293F6DQ42698863-E3C01140-9283-406F-94DB-385CD7D635EEQ46670559-61F17579-AD39-4CAD-9D30-71940899581BQ47569690-E003EDF1-9B58-4A68-8480-F56C19257AA4Q49678727-9D6A9D49-A96E-4A21-BE95-5EFCE16DAA97Q55122666-3C68B289-C5B4-4C4F-B910-C8DE847A9D29
P2860
A river model to map convergent cancer evolution and guide therapy in RCC.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A river model to map convergent cancer evolution and guide therapy in RCC.
@en
type
label
A river model to map convergent cancer evolution and guide therapy in RCC.
@en
prefLabel
A river model to map convergent cancer evolution and guide therapy in RCC.
@en
P2860
P356
P1476
A river model to map convergent cancer evolution and guide therapy in RCC.
@en
P2093
Elizabeth Y Wei
James J Hsieh
P2860
P2888
P304
P356
10.1038/NRUROL.2015.260
P407
P577
2015-11-03T00:00:00Z
P6179
1031695553